Bridgeway Capital Management, LLC Enzo Biochem Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 180,800 shares of ENZ stock, worth $177,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,800
Previous 132,100 36.87%
Holding current value
$177,184
Previous $143,000 41.26%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.04 - $1.18 $50,648 - $57,466
48,700 Added 36.87%
180,800 $202,000
Q2 2024

Aug 14, 2024
SELL
$1.04 - $1.28 $98,800 - $121,600
-95,000 Reduced 41.83%
132,100 $143,000
Q3 2023

Nov 14, 2023
SELL
$1.3 - $1.87 $106,988 - $153,899
-82,299 Reduced 26.6%
227,100 $317,000
Q2 2023

Aug 14, 2023
SELL
$1.84 - $2.66 $11,225 - $16,228
-6,101 Reduced 1.93%
309,399 $569,000
Q1 2023

May 15, 2023
SELL
$1.0 - $2.51 $5,200 - $13,051
-5,200 Reduced 1.62%
315,500 $766,000
Q3 2022

Nov 14, 2022
SELL
$2.1 - $2.73 $115,500 - $150,150
-55,000 Reduced 14.64%
320,700 $715,000
Q2 2022

Aug 15, 2022
BUY
$2.0 - $3.0 $600 - $900
300 Added 0.08%
375,700 $778,000
Q1 2022

May 16, 2022
BUY
$2.9 - $3.47 $186,180 - $222,774
64,200 Added 20.63%
375,400 $1.09 Million
Q4 2021

Feb 14, 2022
BUY
$3.17 - $4.09 $110,950 - $143,150
35,000 Added 12.67%
311,200 $999,000
Q3 2021

Nov 15, 2021
BUY
$3.01 - $3.77 $165,550 - $207,350
55,000 Added 24.86%
276,200 $978,000
Q2 2021

Aug 16, 2021
SELL
$2.86 - $3.61 $107,250 - $135,375
-37,500 Reduced 14.5%
221,200 $701,000
Q1 2021

May 17, 2021
SELL
$2.61 - $4.08 $158,427 - $247,656
-60,700 Reduced 19.0%
258,700 $890,000
Q4 2020

Feb 16, 2021
SELL
$1.82 - $2.61 $179,452 - $257,346
-98,600 Reduced 23.59%
319,400 $805,000
Q3 2020

Nov 16, 2020
BUY
$2.02 - $3.02 $329,462 - $492,562
163,100 Added 63.99%
418,000 $882,000
Q2 2020

Aug 14, 2020
SELL
$2.12 - $3.22 $255,672 - $388,332
-120,600 Reduced 32.12%
254,900 $571,000
Q1 2020

May 15, 2020
SELL
$1.82 - $3.87 $92,092 - $195,822
-50,600 Reduced 11.88%
375,500 $950,000
Q3 2019

Nov 14, 2019
SELL
$3.01 - $4.0 $3,912 - $5,200
-1,300 Reduced 0.3%
426,100 $1.53 Million
Q2 2019

Aug 14, 2019
SELL
$2.79 - $4.31 $11,718 - $18,102
-4,200 Reduced 0.97%
427,400 $1.44 Million
Q1 2019

May 15, 2019
BUY
$2.54 - $4.02 $675,640 - $1.07 Million
266,000 Added 160.63%
431,600 $1.18 Million
Q3 2018

Nov 13, 2018
BUY
$3.81 - $5.53 $154,686 - $224,518
40,600 Added 32.48%
165,600 $682,000
Q2 2018

Aug 14, 2018
BUY
$5.06 - $6.78 $632,500 - $847,500
125,000 New
125,000 $649,000

Others Institutions Holding ENZ

# of Institutions
48
Shares Held
15.5M
Call Options Held
2.3K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $47.7M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email